Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002;
Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB et al. The Women’s Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 2004; 81(6):1498-1501.
Naftolin F, Schneider HPG, Sturdee DW, Birkhauser.M., Gambacciani M, Limpaphayom KK et al. Guidelines for hormone treatment of women in the menopausal transition and beyond. Climacteric 2004; 7(4):333-337
